Adenomatoid tumour with perineural space involvement: the utility of next-generation sequencing in this diagnostic conundrum.

Autor: Chan N; Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia. Electronic address: nonilongchan@gmail.com., Kim S; Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia., Rathi V; LifeStrands Genomics, Mt Waverley, Vic, Australia., Delprado W; Douglass Hanly Moir Pathology, Macquarie Park, NSW, Australia; University of Notre Dame, Sydney, NSW, Australia; Macquarie University, Macquarie Park, NSW, Australia., Canagasingham A; Department of Urology, Royal North Shore Hospital, St Leonards, NSW, Australia., Chalasani V; Department of Urology, Royal North Shore Hospital, St Leonards, NSW, Australia., Toon C; Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia; University of New South Wales, Sydney, NSW, Australia.

Publikováno v: Pathology [Pathology] 2024 Oct; Vol. 56 (6), pp. 925-927. Date of Electronic Publication: 2024 Jul 14.

Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.

Autor: Geboers B; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.; Department of Radiology and Nuclear Medicine, Amsterdam UMC (location VUmc), Amsterdam, The Netherlands., Meijer D; Department of Urology, Amsterdam UMC (location VUmc), Amsterdam, The Netherlands., Counter W; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, NSW, Australia., Blazevski A; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia., Thompson J; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.; Department of Urology, St. George Hospital, Sydney, NSW, Australia., Doan P; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia., Gondoputro W; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia., Katelaris A; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia., Haynes AM; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia., Delprado W; Douglas Hanly Moir Pathology, Sydney, NSW, Australia., O'Neill G; Department of Urology, St. Vincent's Hospital and Private Clinic, Sydney, NSW, Australia., Yuen C; Department of Urology, St. Vincent's Hospital and Private Clinic, Sydney, NSW, Australia., Vis AN; Department of Urology, Amsterdam UMC (location VUmc), Amsterdam, The Netherlands., van Leeuwen PJ; Department of Urology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, The Netherlands., Ho B; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, NSW, Australia., Liu V; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, NSW, Australia., Lee J; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, NSW, Australia., Donswijk ML; Department of Radiology and Nuclear Medicine, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, The Netherlands., Oprea-Lager D; Department of Radiology and Nuclear Medicine, Amsterdam UMC (location VUmc), Amsterdam, The Netherlands., Scheltema MJ; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.; Department of Urology, Amsterdam UMC (location VUmc), Amsterdam, The Netherlands., Emmett L; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, NSW, Australia., Stricker PD; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.; Department of Urology, St. Vincent's Hospital and Private Clinic, Sydney, NSW, Australia.

Publikováno v: BJU international [BJU Int] 2024 Apr; Vol. 133 Suppl 4, pp. 14-22. Date of Electronic Publication: 2023 Nov 08.

⁶⁸ Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study.

Autor: Gondoputro W; St Vincent's Prostate Cancer Research Centre, Sydney, Australia.; Garvan Institute of Medical Research, Sydney, Australia., Doan P; St Vincent's Prostate Cancer Research Centre, Sydney, Australia.; Garvan Institute of Medical Research, Sydney, Australia., Katelaris A; St Vincent's Prostate Cancer Research Centre, Sydney, Australia.; Garvan Institute of Medical Research, Sydney, Australia., Scheltema MJ; St Vincent's Prostate Cancer Research Centre, Sydney, Australia.; Garvan Institute of Medical Research, Sydney, Australia., Geboers B; St Vincent's Prostate Cancer Research Centre, Sydney, Australia.; Garvan Institute of Medical Research, Sydney, Australia., Agrawal S; St Vincent's Prostate Cancer Research Centre, Sydney, Australia.; Department of Urology, St Vincent's Private Hospital Sydney, Sydney, Australia., Liu Z; St Vincent's Prostate Cancer Research Centre, Sydney, Australia.; Garvan Institute of Medical Research, Sydney, Australia., Yaxley J; Department of Urology, Wesley Urology Clinic, Brisbane, Australia., Savdie R; Department of Urology, St Vincent's Private Hospital Sydney, Sydney, Australia.; Department of Urology, Prince of Wales Hospital, Sydney, Australia., Rasiah K; Department of Urology, Royal North Shore Hospital, Sydney, Australia., Frydenberg M; Department of Urology, Cabrini Hospital Malvern, Melbourne, Australia., Roberts MJ; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia., Malouf D; Department of Urology, St George Hospital, Sydney, Australia., Wong D; I-MED Radiology Network, Sydney, Australia., Shnier R; I-MED Radiology Network, Sydney, Australia., Delprado W; Douglass Hanly Moir Pathology, Sydney, Australia., Emmett L; Garvan Institute of Medical Research, Sydney, Australia.; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney, Sydney, Australia., Stricker PD; St Vincent's Prostate Cancer Research Centre, Sydney, Australia.; Department of Urology, St Vincent's Private Hospital Sydney, Sydney, Australia., Thompson J; St Vincent's Prostate Cancer Research Centre, Sydney, Australia.; Department of Urology, St Vincent's Private Hospital Sydney, Sydney, Australia.; Department of Urology, St George Hospital, Sydney, Australia.

Publikováno v: Translational andrology and urology [Transl Androl Urol] 2023 Oct 31; Vol. 12 (10), pp. 1598-1606. Date of Electronic Publication: 2023 Oct 07.

Index grade group is superior to composite grade group for prediction of biochemical recurrence following radical prostatectomy.

Autor: Best O; Department of Urology, St George Hospital, Kogarah, NSW, Australia; Kinghorn Cancer Centre, Garvan Institute, Darlinghurst, NSW, Australia., Canagasingham A; Department of Urology, St George Hospital, Kogarah, NSW, Australia; Kinghorn Cancer Centre, Garvan Institute, Darlinghurst, NSW, Australia. Electronic address: ashan_213@hotmail.com., Liu Z; Stats Central, Mark Wainwright Analytical Centre, University of New South Wales, Kensington, NSW, Australia., Doan P; Kinghorn Cancer Centre, Garvan Institute, Darlinghurst, NSW, Australia; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia., Haynes AM; Kinghorn Cancer Centre, Garvan Institute, Darlinghurst, NSW, Australia., Delprado W; Douglass Hanly Moir Pathology, Sonic Healthcare, St Leonards, NSW, Australia., Maclean F; Douglass Hanly Moir Pathology, Sonic Healthcare, St Leonards, NSW, Australia; Faculty of Medicine and Health Sciences, Macquarie University, North Ryde, NSW, Australia., Yuen C; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia., Stricker P; Kinghorn Cancer Centre, Garvan Institute, Darlinghurst, NSW, Australia; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia; Faculty of Medicine, UNSW, Darlinghurst, NSW, Australia., Thompson J; Department of Urology, St George Hospital, Kogarah, NSW, Australia; Kinghorn Cancer Centre, Garvan Institute, Darlinghurst, NSW, Australia; Faculty of Medicine, UNSW, Darlinghurst, NSW, Australia.

Publikováno v: Pathology [Pathology] 2023 Jun; Vol. 55 (4), pp. 492-497. Date of Electronic Publication: 2023 Jan 11.

Salvage irreversible electroporation for radio-recurrent prostate cancer - the prospective FIRE trial.

Autor: Blazevski A; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Department of Urology, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia., Geboers B; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Department of Urology, Darlinghurst, Sydney, New South Wales, Australia., Scheltema MJ; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Department of Urology, Darlinghurst, Sydney, New South Wales, Australia., Gondoputro W; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Department of Urology, Darlinghurst, Sydney, New South Wales, Australia., Doan P; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Department of Urology, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia., Katelaris A; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Department of Urology, Darlinghurst, Sydney, New South Wales, Australia., Agrawal S; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Department of Urology, Darlinghurst, Sydney, New South Wales, Australia., Baretto D; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Department of Urology, Darlinghurst, Sydney, New South Wales, Australia., Matthews J; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Department of Urology, Darlinghurst, Sydney, New South Wales, Australia., Haynes AM; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Department of Urology, Darlinghurst, Sydney, New South Wales, Australia., Delprado W; Douglass Hanly Moir Pathology, Sydney, New South Wales, Australia., Shnier R; I-MED Radiology, Sydney, New South Wales, Australia., van den Bos W; Amsterdam UMC, Department of Radiology and Nuclear Medicine, Amsterdam, the Netherlands., Thompson JE; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Department of Urology, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia., Lawrentschuk N; University of Melbourne, Melbourne, Victoria, Australia.; EJ Whitten Prostate Cancer Research Centre at Epworth, Melbourne, Victoria, Australia., Stricker PD; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Department of Urology, Darlinghurst, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Publikováno v: BJU international [BJU Int] 2023 Jun; Vol. 131 Suppl 4, pp. 23-31. Date of Electronic Publication: 2023 Jan 09.